Cryptic chromosomal aberrations leading to an AML1/ETO rearrangement are frequently caused by small insertions

Genes Chromosomes and Cancer

Volumn 36, Issue 3, 2003, Pages 261-272

  Gamerdinger, Ulrike ^a   Teigler Schlegel, Andrea ^a   Pils, Sabine ^a   Bruch, Jochen ^a   Viehmann, Susanne ^a   Keller, Monika ^b   Jauch, Anna ^b   Harbott, Jochen ^a,c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE INSERTION; HUMAN; HUMAN TISSUE; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CYTOGENETIC ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GENE REARRANGEMENT; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MALE; MUTAGENESIS, INSERTIONAL; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0037358377     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10168     Document Type: Article

References (44)

1. Archidiacono N, Antonacci R, Marzella R, Finelli P, Lonoce A, Rocchi M. 1995. Comparative mapping of human alphoid sequences in great apes using fluorescence in situ hybridization. Genomics 25:477-484.
2. Azofeifa J, Fauth C, Kraus J, Maierhofer C, Langer S, Bolzer A, Reichman J, Schuffenhauer S, Speicher MR. 2000. An optimized probe set for the detection of small interchromosomal aberrations by use of 24-color FISH. Am J Hum Genet 66:1684-1688.
3. Berger R, Coniat MB. 2000. Uneven frequencies of secondary chromosomal abnormalities in acute myeloid leukemias with t(8;21), t(15;17), and inv(16). Cancer Genet Cytogenet 117:159-162.
4. Berger R, Flandrin G, Bernheim A, Le Coniat M, Vecchione D, Pacot A, Derre J, Daniel MT, Valensi F, Sigaux F. 1987. Cytogenetic studies on 519 consecutive de novo acute nonlymphocyticleukemias. Cancer Genet Cytogenet 29:9-21.
5. Cremer T, Lichter P, Borden J, Ward DC, Manuelidis L. 1988. Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosomespecific library probes. Hum Genet 80:235-246.
6. Downing JR, Head DR, Curcio-Brint AM, Hulshof MG, Motroni TA, Raimondi SC, Carroll AJ, Drabkin HA, Willman C, Theil KS. 1993. An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood 81: 2860-2865.
7. Gallego M, Carroll AJ, Gad GS, Pappo A, Head D, Behm F, Ravindranath Y, Raimondi SC. 1994. Variant t(8;21) rearrangements in acute myeloblastic leukemia of childhood. Cancer Genet Cytogenet 75:139-144.
8. Giles FJ, Kanemaki TJ, Schreck RR, Qasabian L, Fuerst MP, Lim SW. 1998. Translocation (3;21;8)(q21;q22;q22) in a patient with acute myeloid leukemia. A case report and review of prognostic indicators. Cancer Genet Cytogenet 104:66-69.
9. Grimwade D. 2001. The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia. Best Pract Res Clin Haematol 14:497-529.
10. Grimwade D. 2002. Screening for core binding factor gene rearrangements in acute myeloid leukemia. Leukemia 16:964-969.
11. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A. 1998. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92:2322-2333.
12. Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ, Wheatley K, Burnett AK, Goldstone AH. 2001. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98:1312-1320.
13. Guan XY, Zhang H, Bittner M, Jiang Y, Meltzer P, Trent J. 1996. Chromosome arm painting probes. Nat Genet 12:10-11.
14. Hagemeijer A, Buijs A, Smit E, Janssen B, Creemers GJ, van der PD, Grosveld G. 1993. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia. Genes Chromosomes Cancer 8:237-245.
15. Hagemeijer A, de Klein A, Wijsman J, van Meerten E, de Greef GE, Sacchi N. 1998. Development of an interphase fluorescent in situ hybridization (FISH) test to detect t(8;21) in AML patients. Leukemia 12:96-101.
16. Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F. 1997. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood 90:4933-4937.
17. Harrison CJ, Radford-Weiss I, Ross F, Rack K, le Guyader G, Vekemans M, Macintyre E. 1999. Fluorescence in situ hybridization analysis of masked (8;21)(q22;q22) translocations. Cancer Genet Cytogenet 112:15-20.
18. Harrison CJ, Yang F, Butler T, Cheung KL, O'Brien PC, Hennessy BJ, Prentice HG, Ferguson-Smith M. 2001. Cross-species color banding in ten cases of myeloid malignancies with complex karyotypes. Genes Chromosomes Cancer 30:15-24.
19. ISCN. 1995. An international system for human cytogenetic nomenclature. Mitelman F, editor. Basel: S. Karger.
20. Ishida F, Ueno M, Tanaka H, Makishima H, Suzawa K, Hosaka S, Hidaka E, Ishikawa M, Yamauchi K, Kitano K, Kiyosawa K. 2002. t(8;21;14)(q22;q22;q24) is a novel variant of t(8;21) with chimeric transcripts of AML1-ETO in acute myelogenous leukemia. Cancer Genet Cytogenet 132:133-135.
21. Kazama H, Aoyama M, Sameshima Y, Teramura M, Masuda M, Motoji T, Okada M, Mizoguchi H. 1996. Acute myelogenous leukemia with ins(21;8) expressing AML-1-MTG8 fusion transcript. Rinsho Ketsueki 37:1297-1302.
22. Krauter J, Ganser A, Bergmann L, Raghavachar A, Hoelzer D, Lubbert M, Schlimok G, Arnold R, Kirchner H, Port M, Heil G. 1999. Association between structural and numerical chromosomal aberrations in acute myeloblastic leukemia: a study by RT-PCR and FISH in 447 patients with de-novo AML. Ann Hematol 78:265-269.
23. Lengauer C, Dunham I, Featherstone T, Cremer T. 1994. Generation of alphoid DNA probes for fluorescence in situ hybridization (FISH) using the polymerase chain reaction. In: Choo KHA, editor. In situ hybridization protocols. Totowa, NJ: Humana Press. p. 51-61.
24. Maruyama F, Stass SA, Estey EH, Cork A, Hirano M, Ino T, Freireich EJ, Yang P, Chang KS. 1994. Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia. Leukemia 8:40-45.
25. Nucifora G, Dickstein JI, Torbenson V, Roulston D, Rowley JD, Vardiman JW. 1994. Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). Leukemia 8:1533-1538.
26. Rao PH, Cigudosa JC, Ning Y, Calasanz MJ, Iida S, Tagawa S, Michaeli J, Klein B, Dalla-Favera R, Jhanwar SC, Ried T, Chaganti RS. 1998. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma. Blood 92:1743-1748.
27. Ritterbach J, Harbott J, Ritter J, Lampert F. 1990. Chromosomal aberrations in childhood acute nonlymphoblastic leukemia. Haematol Bluttransfus 33:153-156.
28. Rowley JD. 1973. Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia. Ann Genet 16:109-112.
29. Sacchi N, Magnani I, Kearney L, Wijsman J, Hagemeijer A, Darfler M. 1995. Interphase cytogenetics of the t(8;21)(q22;q22) associated with acute myelogenous leukemia by two-color fluorescence in situ hybridization. Cancer Genet Cytogenet 79:97-103.
30. Saitoh K, Miura I, Ohshima A, Takahashi N, Kume M, Utsumi S, Kobayashi Y, Hashimoto K, Hatano Y, Nimura T, Saito M, Enomoto K, Ohhira M, Shimizu K, Ohki M, Miura AB. 1997. Translocation (8;12;21)(q22.1;q24.1;q22.1): a new masked type of t(8; 21)(q22;q22) in a patient with acute myeloid leukemia. Cancer Genet Cytogenet 96:111-114.
31. Schlieben S, Borkhardt A, Reinisch I, Ritterbach J, Janssen JW, Ratei R, Schrappe M, Repp R, Zimmermann M, Kabisch H, Janka-Schaub G, Bartram CR, Ludwig WD, Riehm H, Lampert F, Harbott J. 1996. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. Leukemia 10:957-963.
32. Scholz I, Popp S, Granzow M, Schoell B, Holtgreve-Grez H, Takeuchi S, Schrappe M, Harbott J, Teigler-Schlegel A, Zimmermann M, Fischer C, Koeffler HP, Bartram CR, Jauch A. 2001. Comparative genomic hybridization in childhood acute lymphoblastic leukemia: correlation with interphase cytogenetics and loss of heterozygosity analysis. Cancer Genet Cytogenet 124:89-97.
33. Shinagawa A, Komatsu T, Ninomiya H. 1999. Complex translocation (6;21;8), a variant of t(8;21), with trisomy 4 in a patient with acute myelogenous leukemia (M2). Cancer Genet Cytogenet 109: 72-75.
34. Starza RL, Matteucci C, Crescenzi B, Perla G, Carotenuto M, Martelli MF, Hagemeijer A, Mecucci C. 1997. Identification of chromosome changes in acute myeloid leukemia (AML-M2) by molecular cytogenetics. Cancer Genet Cytogenet 95:148-152.
35. Taviaux S, Brunel V, Dupont M, Fernandez F, Ferraz C, Carbuccia N, Sainty D, Demaille J, Birg F, Lafage-Pochitaloff M. 1999. Simple variant t(8;21) acute myeloid leukemias harbor insertions of the AML1 or ETO genes. Genes Chromosomes Cancer 24: 165-171.
36. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A. 1992. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 13:718-725.
37. Urioste M, Martinez-Ramirez A, Cigudosa JC, Mateo MS, Martinez P, Contra T, Benitez J. 2002. Identification of ins(8;21) with AML1/ETO fusion in acute myelogenous leukemia M2 by molecular cytogenetics. Cancer Genet Cytogenet 133:83-86.
38. Van Hemel JO, Eussen HJ. 2000. Interchromosomal insertions. Identification of five cases and a review. Hum Genet 107:415-432.
39. Veldman T, Vignon C, Schrock E, Rowley JD, Ried T. 1997. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 15:406-410.
40. Vieira L, Oliveira V, Ambrosio AP, Marques B, Pereira AM, Hagemeijer A, Boavida MG. 2001. Translocation (8;17;15;21)(q22;q23; q15;q22) in acute myeloid leukemia (M2). A four-way variant of t(8;21). Cancer Genet Cytogenet 128:104-107.
41. Wong KF, Kwong YL, So CC. 1998. Translocation(8;20;21)(q22;q13; q22) in acute myeloblastic leukemia with maturation: a variant form of t(8;21). Cancer Genet Cytogenet 101:39-41.
42. Xue Y, Niu C, Chen S, Wang Y, Guo Y, Xie X, Lu D, Li P. 2000. Two cases of AML (M2) with a t(8;19)(q22;q13): a new cytogenetic variant. Cancer Genet Cytogenet 118:154-158.
43. Xue Y, Chen S, Xiong H, Niu C, Chen B, Guo Y, Wu Y. 2001. AML1 and ETO genes implicated in an acute myeloblastic leukemia patient with t(8;19). Cancer Genet Cytogenet 125:80.
44. Zhang FF, Murata-Collins JL, Gaytan P, Forman SJ, Kopecky KJ, Willman CL, Appelbaum FR, Slovak ML. 2000. Twenty-fourcolor spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemia. Genes Chromosomes Cancer 28:318-328.